Health Care Utilization and Cost Associated with Biologic Treatment Patterns Among Patients with Moderate to Severe Psoriasis: Analyses from a Large U.S. Claims Database-Reference-Cited by-同舟云学术

Health Care Utilization and Cost Associated with Biologic Treatment Patterns Among Patients with Moderate to Severe Psoriasis: Analyses from a Large U.S. Claims Database

Published:2019-04 Issue:4 Volume:25 Page:479-488
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Feldman Steven R.¹,Tian Haijun²,Wang Xinyue³,Germino Rebecca⁴

Affiliation:

1. Department of Dermatology, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina.

2. Center of Excellence for Real World Evidence, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.

3. KMK Consulting, Morristown, New Jersey.

4. Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving systemic therapy selection for inflammatory skin diseases: A clinical need survey;JAAD International;2024-09

2. Treatment switching and associated economic outcomes in patients with plaque psoriasis treated with biologics: A retrospective analysis of German claims data 2016−2021;JEADV Clinical Practice;2024-08-27

3. Drug survival for biologics in psoriasis patients: real world evidence for Greece during the period 2016-2020;Clinical and Experimental Dermatology;2024-07-06

4. Healthcare resource utilization patterns in psoriasis patients using biologic and conventional treatments in Finland;Frontiers in Immunology;2024-06-10

5. Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan;Journal of Dermatological Treatment;2024-02-05